Milestone Pharmaceuticals
logo BDC

Milestone Pharmaceuticals

Milestone is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone’s lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.

Investment year:  2012
Industry sector:  Drugs
Region:  Quebec
Follow Milestone Pharmaceuticals

Recent news

Milestone Pharmaceuticals Closes $55 Million Series C Financing

Learn More
BDC Venture Capital Partner

Amine Benmoussa